Research graph
References from Diagnostic value of CEUS-VI-RADS for predicting muscle invasion in bladder cancer: Validation of the scoring system and introduction of tumor-bladder wall contact length as a supplementary quantitative metric. Local targets link to admitted publications; unresolved targets remain external evidence.
Bladder cancer incidence and mortality: a global overview and recent trends
10.1016/j.eururo.2016.06.010 · 2017 · External reference
Regional, and national burden of bladder cancer, 1990-2019: an age-period-cohort analysis based on the Global Burden of Disease 2019 study
10.1016/j.puhe.2024.07.027 · 2024 · External reference
A systematic review of novel intravesical approaches for the treatment of patients with non-muscle-invasive bladder cancer
10.1016/j.eururo.2025.02.010 · 2025 · External reference
Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy
10.1111/bju.12245 · 2014 · External reference
Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience
10.1016/j.eururo.2009.05.047 · 2010 · External reference
Contrast-enhanced ultrasound enables precision diagnosis of preoperative muscle invasion in bladder cancer: a prospective study
2025 · External reference
Multiparametric Magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System)
10.1016/j.eururo.2018.04.029 · 2018 · External reference
The comparison between contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging in diagnosing bladder urothelial carcinoma
10.1007/s11255-022-03410-2 · 2023 · External reference
Can the vesical Imaging reporting and data system (VI-RADS) score be applied in conventional ultrasound and contrast-enhanced ultrasound to differentiate muscle-invasive bladder cancer?
10.11152/mu-3841 · 2023 · External reference
Development and validation of a contrast-enhanced US VI-RADS for evaluating muscle invasion in bladder cancer
10.1148/radiol.232815 · 2024 · External reference
Evaluation of extracapsular extension in prostate cancer using qualitative and quantitative multiparametric MRI
10.1002/jmri.25515 · 2017 · External reference
Quantitation of bladder cancer for the prediction of muscle layer invasion as a complement to the vesical imaging-reporting and data system
10.1007/s00330-020-07224-7 · 2021 · External reference
The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations
10.5152/dir.2019.18458 · 2019 · External reference
Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma
10.2214/ajr.14.13147 · 2015 · External reference
Urinary bladder cancer: diffusion-weighted MR imaging—accuracy for diagnosing T stage and estimating histologic grade
10.1148/radiol.2511080873 · 2009 · External reference
News in the classification of WHO 2022 bladder tumors
2022 · External reference
Evaluation of extracapsular extension in prostate cancer using qualitative and quantitative multiparametric MRI
10.1002/jmri.25515 · ExternalCitation · doi-reference
Quantitation of bladder cancer for the prediction of muscle layer invasion as a complement to the vesical imaging-reporting and data system
10.1007/s00330-020-07224-7 · ExternalCitation · doi-reference
The comparison between contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging in diagnosing bladder urothelial carcinoma
10.1007/s11255-022-03410-2 · ExternalCitation · doi-reference
Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience
10.1016/j.eururo.2009.05.047 · ExternalCitation · doi-reference
Bladder cancer incidence and mortality: a global overview and recent trends
10.1016/j.eururo.2016.06.010 · ExternalCitation · doi-reference
Multiparametric Magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System)
10.1016/j.eururo.2018.04.029 · ExternalCitation · doi-reference
A systematic review of novel intravesical approaches for the treatment of patients with non-muscle-invasive bladder cancer
10.1016/j.eururo.2025.02.010 · ExternalCitation · doi-reference
Regional, and national burden of bladder cancer, 1990-2019: an age-period-cohort analysis based on the Global Burden of Disease 2019 study
10.1016/j.puhe.2024.07.027 · ExternalCitation · doi-reference
Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy
10.1111/bju.12245 · ExternalCitation · doi-reference
Can the vesical Imaging reporting and data system (VI-RADS) score be applied in conventional ultrasound and contrast-enhanced ultrasound to differentiate muscle-invasive bladder cancer?
10.11152/mu-3841 · ExternalCitation · doi-reference
Development and validation of a contrast-enhanced US VI-RADS for evaluating muscle invasion in bladder cancer
10.1148/radiol.232815 · ExternalCitation · doi-reference
Urinary bladder cancer: diffusion-weighted MR imaging—accuracy for diagnosing T stage and estimating histologic grade
10.1148/radiol.2511080873 · ExternalCitation · doi-reference
Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma
10.2214/ajr.14.13147 · ExternalCitation · doi-reference
The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations
10.5152/dir.2019.18458 · ExternalCitation · doi-reference
